These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26568008)

  • 1. Nanoparticle Albumin-bound Paclitaxel+Carboplatin Therapy for Small Cell Lung Cancer Combined with Squamous Cell Carcinoma and Interstitial Lung Disease.
    Azuma Y; Tamiya M; Shiroyama T; Osa A; Takeoka S; Morishita N; Suzuki H; Okamoto N; Hirashima T; Kawase I
    Intern Med; 2015; 54(22):2911-3. PubMed ID: 26568008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancer.
    Grilley-Olson JE; Keedy VL; Sandler A; Moore DT; Socinski MA; Stinchcombe TE
    Oncologist; 2015 Feb; 20(2):105-6. PubMed ID: 25616430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301.
    Miyauchi E; Inoue A; Usui K; Sugawara S; Maemondo M; Saito H; Fujita Y; Kato T; Suzuki T; Harada T; Watanabe H; Nakagawa T; Ichinose M
    Oncologist; 2017 Jun; 22(6):640-e59. PubMed ID: 28526722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302).
    Asahina H; Oizumi S; Takamura K; Harada T; Harada M; Yokouchi H; Kanazawa K; Fujita Y; Kojima T; Sugaya F; Tanaka H; Honda R; Kikuchi E; Ikari T; Ogi T; Shimizu K; Suzuki M; Konno S; Dosaka-Akita H; Isobe H; Nishimura M;
    Lung Cancer; 2019 Dec; 138():65-71. PubMed ID: 31654836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias.
    Fujita T; Hiroishi T; Shikano K; Yanagisawa A; Hayama N; Amano H; Nakamura M; Hirano S; Tabeta H; Nakamura S
    Intern Med; 2018 Jul; 57(13):1827-1832. PubMed ID: 29434143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.
    Reynolds C; Barrera D; Jotte R; Spira AI; Weissman C; Boehm KA; Pritchard S; Asmar L
    J Thorac Oncol; 2009 Dec; 4(12):1537-43. PubMed ID: 19887966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
    Akiyama N; Karayama M; Inui N; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inami N; Matsuura S; Kaida Y; Uto T; Matsui T; Asada K; Matsuda H; Fujii M; Toyoshima M; Suda T
    Invest New Drugs; 2019 Jun; 37(3):531-537. PubMed ID: 30790149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.
    Kogure Y; Saka H; Takiguchi Y; Atagi S; Kurata T; Ebi N; Inoue A; Kubota K; Takenoyama M; Seto T; Kada A; Yamanaka T; Ando M; Yamamoto N; Gemma A; Ichinose Y
    Clin Lung Cancer; 2018 Sep; 19(5):e711-e715. PubMed ID: 29861395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.
    Socinski MA; Bondarenko I; Karaseva NA; Makhson AM; Vynnychenko I; Okamoto I; Hon JK; Hirsh V; Bhar P; Zhang H; Iglesias JL; Renschler MF
    J Clin Oncol; 2012 Jun; 30(17):2055-62. PubMed ID: 22547591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of nanoparticle albumin-bound paclitaxel plus carboplatin in non-small lung cancer patients with malignant pleural effusion.
    Koyama N; Watanabe Y; Iwai Y; Miwa C; Nagai Y; Aoshiba K; Nakamura H
    Neoplasma; 2018; 65(1):132-139. PubMed ID: 29322797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease.
    Yasuda Y; Hattori Y; Tohnai R; Ito S; Kawa Y; Kono Y; Urata Y; Nogami M; Takenaka D; Negoro S; Satouchi M
    Jpn J Clin Oncol; 2018 Jan; 48(1):89-93. PubMed ID: 29036303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease.
    Fujimoto D; Shimizu R; Kato R; Sato Y; Kogo M; Ito J; Teraoka S; Otoshi T; Nagata K; Nakagawa A; Otsuka K; Katakami N; Tomii K
    Anticancer Res; 2015 Nov; 35(11):6261-6. PubMed ID: 26504060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with carboplatin and paclitaxel for small cell lung cancer.
    Mouri A; Yamaguchi O; Miyauchi S; Shiono A; Utsugi H; Nishihara F; Murayama Y; Kagamu H; Kobayashi K
    Respir Investig; 2019 Jan; 57(1):34-39. PubMed ID: 30528688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and Safety of Carboplatin/Nanoparticle Albumin-Bound Paclitaxel Combination Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer or Recurrent Non-Small-Cell Lung Cancer Following Surgery].
    Shimabukuro I; Noguchi S; Uyama K; Torii R; Ishimoto H; Yoshii C; Tanaka F; Yatera K; Mukae H
    Gan To Kagaku Ryoho; 2018 Sep; 45(9):1305-1310. PubMed ID: 30237372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study.
    Shiroyama T; Tamiya M; Minami S; Takata S; Masuhiro K; Futami-Nishijima Y; Uenami T; Mori M; Koba T; Matsuki T; Takimoto T; Suzuki H; Okamoto N; Komuta K; Hirashima T; Kumanogoh A; Kijima T
    Cancer Chemother Pharmacol; 2017 Sep; 80(3):461-467. PubMed ID: 28688052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study.
    Araya T; Kita T; Ueda T; Terada N; Sakai T; Yamamura K; Kurokawa K; Uchida Y; Sone T; Kimura H; Kasahara K
    Can Respir J; 2019; 2019():5315903. PubMed ID: 31015884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin plus nab-paclitaxel for recurrent small cell lung cancer: A phase II study.
    Ikeda N; Arai R; Soda S; Inoue T; Uchida N; Nakamura Y; Masawa M; Kushima Y; Okutomi H; Takemasa A; Shimizu Y; Niho S
    Thorac Cancer; 2022 May; 13(9):1342-1348. PubMed ID: 35318811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of nab-paclitaxel plus carboplatin in combination with thoracic radiation in patients with locally advanced non-small-cell lung cancer.
    Hasegawa T; Futamura Y; Horiba A; Yoshida T; Suzuki T; Kato T; Kaito D; Ohno Y; Iida T; Hayashi S; Sawa T
    J Radiat Res; 2016 Jan; 57(1):50-4. PubMed ID: 26442970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients.
    Bertino EM; Williams TM; Nana-Sinkam SP; Shilo K; Chatterjee M; Mo X; Rahmani M; Phillips GS; Villalona-Calero MA; Otterson GA
    Clin Lung Cancer; 2015 Nov; 16(6):466-74. PubMed ID: 26123189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nab-paclitaxel plus carboplatin as an effective and safe chemotherapy regimen for pulmonary carcinosarcoma with interstitial lung disease: A case report.
    Niwa H; Otani S; Nakada N; Sasaki J; Saka H; Masuda N
    Respir Med Case Rep; 2018; 23():131-135. PubMed ID: 29719799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.